Long-term CD4+ cell count in response to combination antiretroviral therapy

Detalhes bibliográficos
Autor(a) principal: Luz, Paula Mendes
Data de Publicação: 2014
Outros Autores: Grinsztejn, Beatriz, Velasque, Luciane de Souza, Pacheco, Antonio Guilherme Fonseca, Santos, Valdiléa Gonçalves Veloso dos, Moore, Richard D., Struchiner, Claudio Jose
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da FIOCRUZ (ARCA)
Texto Completo: https://www.arca.fiocruz.br/handle/icict/10498
Resumo: CNPq, FAPERJ, NIH
id CRUZ_05c6a8677e5db7837d75a488dad30bd6
oai_identifier_str oai:www.arca.fiocruz.br:icict/10498
network_acronym_str CRUZ
network_name_str Repositório Institucional da FIOCRUZ (ARCA)
repository_id_str 2135
spelling Luz, Paula MendesGrinsztejn, BeatrizVelasque, Luciane de SouzaPacheco, Antonio Guilherme FonsecaSantos, Valdiléa Gonçalves Veloso dosMoore, Richard D.Struchiner, Claudio Jose2015-05-26T17:03:30Z2015-05-26T17:03:30Z2014LUZ, Paula Mendes et al. Long-term CD4+ cell count in response to combination antiretroviral therapy. Plos One, v. 9, n. 4, p. 1-11, Apr. 2014.1932-6203https://www.arca.fiocruz.br/handle/icict/1049810.1371/journal.pone.00930391932-6203CNPq, FAPERJ, NIHFundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Laboratório de Pesquisa Clínica em DST e AIDS. Rio de Janeiro, RJ, Brasil.Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Laboratório de Pesquisa Clínica em DST e AIDS. Rio de Janeiro, RJ, Brasil.Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Laboratório de Pesquisa Clínica em DST e AIDS. Rio de Janeiro, RJ, Brasil / Universidade Federal do Estado do Rio de Janeiro. Departamento de Matemática e Estatística. Rio de Janeiro, RJ, Brasil.Fundação Oswaldo Cruz. Programa de Computação Científica. Rio de Janeiro, RJ, Brasil.Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Laboratório de Pesquisa Clínica em DST e AIDS. Rio de Janeiro, RJ, Brasil.Johns Hopkins University. Department of Medicine. Baltimore, MD, USA.Fundação Oswaldo Cruz. Programa de Computação Científica. Rio de Janeiro, RJ, Brasil.Objective: There is a continuous debate on how to adequately evaluate long-term CD4+ cell count in response to combination antiretroviral therapy (ART) among human immunodeficiency virus (HIV)-infected individuals. Our study evaluated the long-term CD4+ cell count response (up to ten years) after initiation of ART and described the differences in the CD4+ cell count response stratified by pretreatment CD4+ cell count, and other socio-demographic, behavioral, and clinical factors. Methods: The study population included patients starting ART in the clinical cohorts of Rio de Janeiro, Brazil, and Baltimore, United States. Inverse probability of censoring weighting was used to estimate mean annual CD4+ cell counts while adjusting for choice of initial ART regimen, ART discontinuation and losses-to-follow-up. Results: From 1997 to 2011, 3116 individuals started ART; preferred initial regimen was NNRTI-based (63%). The median follow-up time was 5 years, 10% of the individuals had nine or more years of follow-up. Observed CD4+ cell counts increased throughout the ten years of follow-up. Weighted results, in contrast, increased up to year four and plateaued thereafter with 50% of the population reaching CD4+ cell counts of 449/mL or more. Out of all stratification variables considered, only individuals with pre-treatment CD4+ cell counts $350/mL showed increasing CD4+ cell counts over time with 76% surpassing the CD4+ cell count .500/mL threshold at year ten. Conclusion: The present study corroborates the growing body of knowledge advocating early start of ART by showing that only patients who start ART early fully recover to normal CD4+ cell counts.engPublic Library of ScienceRio de JaneiroHIVCD4 antigensHighly active antiretroviral therapyBaltimore/ethnologyBrazil/ethnologyHIVAntígenos CD4Terapia antirretroviral de alta atividadeBaltimore/etnologiaBrasil/etnologiaLong-term CD4+ cell count in response to combination antiretroviral therapyinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleinfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da FIOCRUZ (ARCA)instname:Fundação Oswaldo Cruz (FIOCRUZ)instacron:FIOCRUZLICENSElicense.txtlicense.txttext/plain; charset=utf-82352https://www.arca.fiocruz.br/bitstream/icict/10498/1/license.txtafbdf7d7a9bcf771a1cc7edf5f618413MD51ORIGINALLong-Term CD4+ Cell Count in Response to Combination Antiretroviral Therapy.pdfLong-Term CD4+ Cell Count in Response to Combination Antiretroviral Therapy.pdfapplication/pdf768634https://www.arca.fiocruz.br/bitstream/icict/10498/2/Long-Term%20CD4%2b%20Cell%20Count%20in%20Response%20to%20Combination%20Antiretroviral%20Therapy.pdf9006a1613eef4c6b8a2865013e590912MD52TEXTLong-Term CD4+ Cell Count in Response to Combination Antiretroviral Therapy.pdf.txtLong-Term CD4+ Cell Count in Response to Combination Antiretroviral Therapy.pdf.txtExtracted texttext/plain49060https://www.arca.fiocruz.br/bitstream/icict/10498/3/Long-Term%20CD4%2b%20Cell%20Count%20in%20Response%20to%20Combination%20Antiretroviral%20Therapy.pdf.txt523927ba096b3ff2712ff9b2e346884dMD53icict/104982023-06-15 16:17:35.338oai:www.arca.fiocruz.br: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ório InstitucionalPUBhttps://www.arca.fiocruz.br/oai/requestrepositorio.arca@fiocruz.bropendoar:21352023-06-15T19:17:35Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)false
dc.title.pt_BR.fl_str_mv Long-term CD4+ cell count in response to combination antiretroviral therapy
title Long-term CD4+ cell count in response to combination antiretroviral therapy
spellingShingle Long-term CD4+ cell count in response to combination antiretroviral therapy
Luz, Paula Mendes
Rio de Janeiro
HIV
CD4 antigens
Highly active antiretroviral therapy
Baltimore/ethnology
Brazil/ethnology
HIV
Antígenos CD4
Terapia antirretroviral de alta atividade
Baltimore/etnologia
Brasil/etnologia
title_short Long-term CD4+ cell count in response to combination antiretroviral therapy
title_full Long-term CD4+ cell count in response to combination antiretroviral therapy
title_fullStr Long-term CD4+ cell count in response to combination antiretroviral therapy
title_full_unstemmed Long-term CD4+ cell count in response to combination antiretroviral therapy
title_sort Long-term CD4+ cell count in response to combination antiretroviral therapy
author Luz, Paula Mendes
author_facet Luz, Paula Mendes
Grinsztejn, Beatriz
Velasque, Luciane de Souza
Pacheco, Antonio Guilherme Fonseca
Santos, Valdiléa Gonçalves Veloso dos
Moore, Richard D.
Struchiner, Claudio Jose
author_role author
author2 Grinsztejn, Beatriz
Velasque, Luciane de Souza
Pacheco, Antonio Guilherme Fonseca
Santos, Valdiléa Gonçalves Veloso dos
Moore, Richard D.
Struchiner, Claudio Jose
author2_role author
author
author
author
author
author
dc.contributor.author.fl_str_mv Luz, Paula Mendes
Grinsztejn, Beatriz
Velasque, Luciane de Souza
Pacheco, Antonio Guilherme Fonseca
Santos, Valdiléa Gonçalves Veloso dos
Moore, Richard D.
Struchiner, Claudio Jose
dc.subject.other.pt_BR.fl_str_mv Rio de Janeiro
topic Rio de Janeiro
HIV
CD4 antigens
Highly active antiretroviral therapy
Baltimore/ethnology
Brazil/ethnology
HIV
Antígenos CD4
Terapia antirretroviral de alta atividade
Baltimore/etnologia
Brasil/etnologia
dc.subject.en.pt_BR.fl_str_mv HIV
CD4 antigens
Highly active antiretroviral therapy
Baltimore/ethnology
Brazil/ethnology
dc.subject.decs.pt_BR.fl_str_mv HIV
Antígenos CD4
Terapia antirretroviral de alta atividade
Baltimore/etnologia
Brasil/etnologia
description CNPq, FAPERJ, NIH
publishDate 2014
dc.date.issued.fl_str_mv 2014
dc.date.accessioned.fl_str_mv 2015-05-26T17:03:30Z
dc.date.available.fl_str_mv 2015-05-26T17:03:30Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.citation.fl_str_mv LUZ, Paula Mendes et al. Long-term CD4+ cell count in response to combination antiretroviral therapy. Plos One, v. 9, n. 4, p. 1-11, Apr. 2014.
dc.identifier.uri.fl_str_mv https://www.arca.fiocruz.br/handle/icict/10498
dc.identifier.issn.none.fl_str_mv 1932-6203
dc.identifier.doi.none.fl_str_mv 10.1371/journal.pone.0093039
dc.identifier.eissn.none.fl_str_mv 1932-6203
identifier_str_mv LUZ, Paula Mendes et al. Long-term CD4+ cell count in response to combination antiretroviral therapy. Plos One, v. 9, n. 4, p. 1-11, Apr. 2014.
1932-6203
10.1371/journal.pone.0093039
url https://www.arca.fiocruz.br/handle/icict/10498
dc.language.iso.fl_str_mv eng
language eng
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.publisher.none.fl_str_mv Public Library of Science
publisher.none.fl_str_mv Public Library of Science
dc.source.none.fl_str_mv reponame:Repositório Institucional da FIOCRUZ (ARCA)
instname:Fundação Oswaldo Cruz (FIOCRUZ)
instacron:FIOCRUZ
instname_str Fundação Oswaldo Cruz (FIOCRUZ)
instacron_str FIOCRUZ
institution FIOCRUZ
reponame_str Repositório Institucional da FIOCRUZ (ARCA)
collection Repositório Institucional da FIOCRUZ (ARCA)
bitstream.url.fl_str_mv https://www.arca.fiocruz.br/bitstream/icict/10498/1/license.txt
https://www.arca.fiocruz.br/bitstream/icict/10498/2/Long-Term%20CD4%2b%20Cell%20Count%20in%20Response%20to%20Combination%20Antiretroviral%20Therapy.pdf
https://www.arca.fiocruz.br/bitstream/icict/10498/3/Long-Term%20CD4%2b%20Cell%20Count%20in%20Response%20to%20Combination%20Antiretroviral%20Therapy.pdf.txt
bitstream.checksum.fl_str_mv afbdf7d7a9bcf771a1cc7edf5f618413
9006a1613eef4c6b8a2865013e590912
523927ba096b3ff2712ff9b2e346884d
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
repository.name.fl_str_mv Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)
repository.mail.fl_str_mv repositorio.arca@fiocruz.br
_version_ 1798324843719950336